HeartSciences (HSCSW) Invested Capital (2021 - 2026)

HeartSciences has reported Invested Capital for 6 years, with the latest figure at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 48.44% year-over-year to $2.7 million; the trailing twelve-month figure through Jan 2026 stood at $2.7 million (up 48.44% YoY), and the FY2025 full-year result was $205171.0, down 97.2% from the prior year.
• Invested Capital for Q1 2026 stood at $2.7 million, down from $4.2 million in the prior quarter.
• The five-year high for Invested Capital was $8.6 million in Q1 2024, with the low at -$6.1 million in Q2 2022.
• Historically, Invested Capital has averaged $1.7 million across 5 years, with a median of $1.8 million in 2025.
• Annual changes were most pronounced in 2023 — Invested Capital slumped 252.37% — and 2024, when it jumped 3447.59%.
• HeartSciences' Invested Capital stood at $1.1 million in 2022, then tumbled by 252.37% to -$1.6 million in 2023, then soared by 343.48% to $4.0 million in 2024, then rose by 4.13% to $4.2 million in 2025, then tumbled by 36.59% to $2.7 million in 2026.
• The last three Invested Capital figures came in at $2.7 million (Q1 2026), $4.2 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.